116 related articles for article (PubMed ID: 1704066)
1. Synthesis and anti-HIV activities of low molecular weight aurintricarboxylic acid fragments and related compounds.
Cushman M; Kanamathareddy S; De Clercq E; Schols D; Goldman ME; Bowen JA
J Med Chem; 1991 Jan; 34(1):337-42. PubMed ID: 1704066
[TBL] [Abstract][Full Text] [Related]
2. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: direct correlation of antiviral potency with molecular weight.
Cushman M; Wang PL; Chang SH; Wild C; De Clercq E; Schols D; Goldman ME; Bowen JA
J Med Chem; 1991 Jan; 34(1):329-37. PubMed ID: 1704065
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions.
Cushman M; Sherman P
Biochem Biophys Res Commun; 1992 May; 185(1):85-90. PubMed ID: 1599491
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E
J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
[TBL] [Abstract][Full Text] [Related]
6. Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates.
Paul GC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
Bioorg Med Chem Lett; 2000 Sep; 10(18):2149-52. PubMed ID: 10999491
[TBL] [Abstract][Full Text] [Related]
7. Potential anti-AIDS agents. Synthesis and antiviral activity of naphthalenesulfonic acid derivatives against HIV-1 and HIV-2.
Mohan P; Singh R; Baba M
J Med Chem; 1991 Jan; 34(1):212-7. PubMed ID: 1704064
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a cosalane analog with an extended polyanionic pharmacophore conferring enhanced potency as an anti-HIV agent.
Cushman M; Insaf S; Ruell JA; Schaeffer CA; Rice WG
Bioorg Med Chem Lett; 1998 Apr; 8(7):833-6. PubMed ID: 9871550
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments.
Casimiro-Garcia A; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Fanwick PE; Cushman M
Bioorg Med Chem; 2001 Nov; 9(11):2827-41. PubMed ID: 11597463
[TBL] [Abstract][Full Text] [Related]
10. Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores.
Santhosh KC; Paul GC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
J Med Chem; 2001 Mar; 44(5):703-14. PubMed ID: 11262081
[TBL] [Abstract][Full Text] [Related]
11. Cosalane and its analogues: a unique class of anti-HIV agents.
Zhan P; Li Z; Liu X
Mini Rev Med Chem; 2010 Sep; 10(10):966-76. PubMed ID: 20540707
[TBL] [Abstract][Full Text] [Related]
12. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
Cushman M; Golebiewski WM; Pommier Y; Mazumder A; Reymen D; De Clercq E; Graham L; Rice WG
J Med Chem; 1995 Feb; 38(3):443-52. PubMed ID: 7853337
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV activity of cosalane.
Choo V
Lancet; 1993 Sep; 342(8873):733. PubMed ID: 8103830
[No Abstract] [Full Text] [Related]
14. Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency.
Cushman M; Insaf S; Paul G; Ruell JA; De Clercq E; Schols D; Pannecouque C; Witvrouw M; Schaeffer CA; Turpin JA; Williamson K; Rice WG
J Med Chem; 1999 May; 42(10):1767-77. PubMed ID: 10346929
[TBL] [Abstract][Full Text] [Related]
15. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.
Schols D; Baba M; Pauwels R; Desmyter J; De Clercq E
Proc Natl Acad Sci U S A; 1989 May; 86(9):3322-6. PubMed ID: 2566170
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.
Cushman M; Golebiewski WM; McMahon JB; Buckheit RW; Clanton DJ; Weislow O; Haugwitz RD; Bader JP; Graham L; Rice WG
J Med Chem; 1994 Sep; 37(19):3040-50. PubMed ID: 7932526
[TBL] [Abstract][Full Text] [Related]
18. [The anti-HIV activity of beta-glycyrrhizic acid].
Pliasunova OA; Egoricheva IN; Fediuk NV; Pokrovskiĭ AG; Baltina LA; Murinov IuI; Tolstikov GA
Vopr Virusol; 1992; 37(5-6):235-8. PubMed ID: 1290221
[TBL] [Abstract][Full Text] [Related]
19. Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors.
Mohan P; Schols D; Baba M; De Clercq E
Antiviral Res; 1992 Jun; 18(2):139-50. PubMed ID: 1384428
[TBL] [Abstract][Full Text] [Related]
20. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action.
Witvrouw M; Weigold H; Pannecouque C; Schols D; De Clercq E; Holan G
J Med Chem; 2000 Mar; 43(5):778-83. PubMed ID: 10715146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
